|
Revenue
|
|
$64.5m
|
$80.3m
|
$131.3m
|
$117.1m
|
$138.8m
|
$183.0m
|
$224.3m
|
$270.3m
|
|
Cost of revenue
|
|
$16.7m
|
$24.2m
|
$51.2m
|
$43.7m
|
$54.2m
|
$70.2m
|
$91.1m
|
$114.8m
|
|
Gross profit
|
|
$47.8m
|
$56.0m
|
$80.1m
|
$73.4m
|
$84.7m
|
$112.8m
|
$133.2m
|
$155.5m
|
|
Research and development
|
|
$0
|
$848k
|
$1.1m
|
$2.1m
|
$2.7m
|
$2.8m
|
$3.1m
|
$3.0m
|
|
Selling, general and administrative
|
|
$34.3m
|
$41.4m
|
$52.8m
|
$54.9m
|
$68.2m
|
$87.9m
|
$106.2m
|
$121.4m
|
|
Income from operations
|
|
$10.1m
|
$8.9m
|
$26.8m
|
$11.6m
|
$8.3m
|
$14.3m
|
$17.9m
|
$22.9m
|
|
Stock-based compensation
|
|
$2.7m
|
$3.9m
|
$4.9m
|
$5.2m
|
$5.2m
|
$5.8m
|
$6.3m
|
$9.1m
|
|
Depreciation and amortization
|
|
$588k
|
$671k
|
$816k
|
$851k
|
$1.0m
|
$1.4m
|
$1.5m
|
$1.5m
|
|
Loss (gain) on disposal of property and equipment
|
|
$54k
|
$360k
|
($2.3m)
|
$448k
|
$346k
|
$645k
|
($1.9m)
|
($2.2m)
|
|
Income (loss) from investments
|
|
—
|
$110k
|
($91k)
|
($1.2m)
|
$935k
|
$485k
|
($954k)
|
$0
|
|
Provision for income taxes
|
|
$162k
|
$271k
|
($5.2m)
|
$3.4m
|
$2.8m
|
$4.1m
|
$4.8m
|
$6.4m
|
|
Net income before taxes
|
|
$9.7m
|
$8.8m
|
$26.4m
|
$12.5m
|
$9.0m
|
$14.4m
|
$16.2m
|
$21.8m
|
|
Net income
|
|
$9.5m
|
$8.5m
|
$31.5m
|
$9.1m
|
$6.2m
|
$10.2m
|
$11.4m
|
$15.4m
|
|
Net income attributable to Viemed Healthcare, Inc.
|
|
$9.5m
|
$8.5m
|
$31.5m
|
$9.1m
|
$6.2m
|
$10.2m
|
$11.3m
|
$14.9m
|
|
Net income attributable to noncontrolling interest
|
|
—
|
—
|
—
|
—
|
$0
|
$0
|
$144k
|
$442k
|
|
Basic (in USD per share)
|
|
$0.26
|
$0.23
|
$0.68
|
$0.32
|
$0.23
|
$0.38
|
$0.42
|
$0.56
|
|
Diluted (in USD per share)
|
|
$0.24
|
$0.22
|
$0.65
|
$0.31
|
$0.23
|
$0.36
|
$0.40
|
$0.53
|
|
Other expense (income), net
|
|
—
|
$3k
|
($4.0m)
|
($1.6m)
|
($989k)
|
($98k)
|
$173k
|
($252k)
|
|
Interest expense, net
|
|
$181k
|
$314k
|
$509k
|
$318k
|
($197k)
|
($424k)
|
($776k)
|
($1.2m)
|